Evidence map›Paper›PMID 20103563›Full record

ReviewPharmacological reviews2010

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Curtis D Klaassen, Lauren M Aleksunes

Open access · bronzeAbstract readReview
In one paragraph

Review in Pharmacological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 321 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
321citing papers in PubMed, 3 pooled it
35.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

321 citing papers in PubMed, 3 syntheses or guidelines pooled it, 793 citations in OpenAlex.

  1. Intestinal microbiota and biliary system diseases.Frontiers in cellular and infection microbiology · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Sensory signals for nausea.Trends in neurosciences · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

261 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Curtis D KlaassenDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7417, USA. cklaasse@kumc.edu
Lauren M Aleksunes
University of Kansas Medical Center · US

Funding

THE ROLE OF HUMAN PXR IN ANTI-TUBERCULOSIS DRUG-INDUCED LIVER INJURYP20RR021940 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MA, XIAOCHAO · 2006 to 2011
$12.1M
TRAINING PROGRAM IN ENVIRONMENTAL TOXICOLOGYT32ES007079 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI HAGENBUCH, BRUNO · 1985 to 2015
$4.1M
Regulation of Hepatic Uptake of Endogenous Signaling Molecules and XenobioticsR01ES009649 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CSANAKY, IVAN · 2000 to 2014
$4.0M
Regulation of Hepatic Excretion of Xenobiotics by MrpsR01ES009716 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2000 to 2010
$3.2M
Coordinate Regulation of Uptake and Efflux TransportersR01ES013714 · NIEHS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2006 to 2010
$1.7M
Nrf2 as a Master Regulator in Liver Disease Prevention and TherapyR01DK081461 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KLAASSEN, CURTIS DEAN · 2009 to 2012
$1.3M
Protective Role of Mrp2 During Chemotherapy-Induced Kidney InjuryR00DK080774 · NIDDK · RUTGERS, THE STATE UNIV OF N.J. · PI ALEKSUNES, LAUREN M · 2009 to 2011
$695k
Protective Role of Mrp2 During Chemotherapy-Induced Kidney InjuryK99DK080774 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ALEKSUNES, LAUREN M · 2008 to 2008
$90k
NCRR NIH HHS P20 RR021940NCRR NIH HHS RR021940NIDDK NIH HHS DK080774NIDDK NIH HHS DK081461NIDDK NIH HHS K99 DK080774NIDDK NIH HHS R00 DK080774NIDDK NIH HHS R01 DK081461NIEHS NIH HHS ES007079NIEHS NIH HHS ES009649NIEHS NIH HHS ES009716NIEHS NIH HHS ES013714NIEHS NIH HHS R01 ES009649NIEHS NIH HHS R01 ES009716NIEHS NIH HHS R01 ES013714NIEHS NIH HHS T32 ES007079
6 · The paper itself

Abstract

Transporters influence the disposition of chemicals within the body by participating in absorption, distribution, and elimination. Transporters of the solute carrier family (SLC) comprise a variety of proteins, including organic cation transporters (OCT) 1 to 3, organic cation/carnitine transporters (OCTN) 1 to 3, organic anion transporters (OAT) 1 to 7, various organic anion transporting polypeptide isoforms, sodium taurocholate cotransporting polypeptide, apical sodium-dependent bile acid transporter, peptide transporters (PEPT) 1 and 2, concentrative nucleoside transporters (CNT) 1 to 3, equilibrative nucleoside transporter (ENT) 1 to 3, and multidrug and toxin extrusion transporters (MATE) 1 and 2, which mediate the uptake (except MATEs) of organic anions and cations as well as peptides and nucleosides. Efflux transporters of the ATP-binding cassette superfamily, such as ATP-binding cassette transporter A1 (ABCA1), multidrug resistance proteins (MDR) 1 and 2, bile salt export pump, multidrug resistance-associated proteins (MRP) 1 to 9, breast cancer resistance protein, and ATP-binding cassette subfamily G members 5 and 8, are responsible for the unidirectional export of endogenous and exogenous substances. Other efflux transporters [ATPase copper-transporting beta polypeptide (ATP7B) and ATPase class I type 8B member 1 (ATP8B1) as well as organic solute transporters (OST) alpha and beta] also play major roles in the transport of some endogenous chemicals across biological membranes. This review article provides a comprehensive overview of these transporters (both rodent and human) with regard to tissue distribution, subcellular localization, and substrate preferences. Because uptake and efflux transporters are expressed in multiple cell types, the roles of transporters in a variety of tissues, including the liver, kidneys, intestine, brain, heart, placenta, mammary glands, immune cells, and testes are discussed. Attention is also placed upon a variety of regulatory factors that influence transporter expression and function, including transcriptional activation and post-translational modifications as well as subcellular trafficking. Sex differences, ontogeny, and pharmacological and toxicological regulation of transporters are also addressed. Transporters are important transmembrane proteins that mediate the cellular entry and exit of a wide range of substrates throughout the body and thereby play important roles in human physiology, pharmacology, pathology, and toxicology.

Indexed as

AnimalsBile Acids and SaltsCarrier ProteinsCholesterolFemaleGene Expression RegulationHumansMaleMembrane GlycoproteinsMembrane Transport ProteinsOrgan SpecificityPhylogenyPolymorphism, GeneticProtein IsoformsProtein Processing, Post-TranslationalProtein Transportbile acid binding proteinsBile Acids and SaltsCarrier ProteinsCholesterolMembrane GlycoproteinsMembrane Transport ProteinsProtein IsoformsXenobiotics

Identifiers

PMID20103563
PMCPMC2835398
OpenAlexW2028890879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.